| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/17/2013 | CN102210739B Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof |
| 04/17/2013 | CN102178663B Nano-analgesic agent and preparation method thereof |
| 04/17/2013 | CN102166334B Externally-applied medicament for treating infantile eczema and senile pruritus and preparation method thereof |
| 04/17/2013 | CN102145177B Method for preparing folate molecular targeted magnetic nanometer medicine carrier and targeting gene medicine |
| 04/17/2013 | CN102106825B Solid zopiclone preparation and preparation method thereof |
| 04/17/2013 | CN102106824B Eszopiclone solid preparation and preparation method thereof |
| 04/17/2013 | CN102106806B Method for preparing solid preparation and solid preparation |
| 04/17/2013 | CN102100663B Method for preparing pH sensitive in-situ gel nano slow-release eye drop |
| 04/17/2013 | CN102083410B Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 04/17/2013 | CN102076324B Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
| 04/17/2013 | CN102076323B Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
| 04/17/2013 | CN102038641B Preparation method of liposome medicine with outer layer modified by hydrophilic polymer |
| 04/17/2013 | CN101993485B Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof |
| 04/17/2013 | CN101926813B Veterinary compound anti-parasitic injection and preparation method thereof |
| 04/17/2013 | CN101921210B Amphiphilic tree-like calixarene used as solubilizer or dispersing agent |
| 04/17/2013 | CN101906141B Conjugates of one class of peptide chain and double fatty alcohol chains as well as preparation method and application thereof |
| 04/17/2013 | CN101890065B Inula flower injection and preparation method thereof |
| 04/17/2013 | CN101843663B Preparation method of extract package of volatile oil heavier than water |
| 04/17/2013 | CN101822646B Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof |
| 04/17/2013 | CN101757063B Soft capsule containing acanthopanax senticosus total saponins and total flavonoids and preparation method thereof |
| 04/17/2013 | CN101721377B Method for preparing microspheres with hydrophilic oil in ethanol, oil in hydrophilic oil, solid in oil |
| 04/17/2013 | CN101653431B Oral mucosa medicament slow release preparation for treating oral periodontal disease and preparation thereof |
| 04/17/2013 | CN101528249B Sustained release formulations comprising very low molecular weight polymers |
| 04/17/2013 | CN101485631B Medicament pellet preparation and preparation method thereof |
| 04/17/2013 | CN101480403B Medicament composition and preparation method thereof |
| 04/17/2013 | CN101474309B Preparation method of composition with anti-fatigue and anti-anoxia functions |
| 04/17/2013 | CN101420983B Methods and compositions comprising supramolecular constructs |
| 04/17/2013 | CN101355927B Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions |
| 04/17/2013 | CN101232902B Noninvasive drug delivery system to posterior part tissue of eye by using solid composition |
| 04/17/2013 | CN101150956B Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 04/17/2013 | CN101150955B Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 04/17/2013 | CN101119706B Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a chelating agent |
| 04/16/2013 | US8420842 Lanolin substitute, production method thereof and applications of same |
| 04/16/2013 | US8420700 Tamper resistant lipid-based oral dosage form for sympathomimetic amines |
| 04/16/2013 | US8420699 Composition and methods of treatment using deionized and ozonated solution |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420130 Pharmaceutical formulation of a didemnin compound |
| 04/16/2013 | US8420123 Drug loaded polymeric nanoparticles and methods of making and using same |
| 04/16/2013 | US8420120 Oral drug delivery system |
| 04/16/2013 | US8420117 Patch formulation for external use |
| 04/16/2013 | US8420116 Dietary compositions for promoting weight loss |
| 04/16/2013 | US8420115 Oral preparations and process for production thereof |
| 04/16/2013 | US8420087 Interleukin-12 targeted to oncofoetal fibronectin |
| 04/16/2013 | US8420086 Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases |
| 04/16/2013 | US8420055 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor |
| 04/16/2013 | CA2714395C Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
| 04/16/2013 | CA2566655C Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 04/16/2013 | CA2538755C Granular jelly drink capable of masking bitterness |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2509153C Hydrolytically stable maleimide-terminated polymers |
| 04/16/2013 | CA2488821C Methods and compositions for grafting functional loops into a protein |
| 04/16/2013 | CA2484512C Treatment of cataracts and other ophthalmic diseases |
| 04/16/2013 | CA2431521E Steroid hormone products and methods for preparing them |
| 04/16/2013 | CA2379087C Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 04/11/2013 | WO2013052889A1 Nasal delivery mechanism for prophylactic and post-acute use for progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries |
| 04/11/2013 | WO2013052760A1 Compositions for the treatment of dry eye |
| 04/11/2013 | WO2013051732A1 Liposome composite body |
| 04/11/2013 | WO2013050930A1 Development of a red clover phytoestrogen product for the prevention or treatment of osteoporosis |
| 04/11/2013 | WO2013050780A1 Stabilisation of polypeptides |
| 04/11/2013 | WO2013050718A1 Method for preparing glycerol derivatives, use thereof, and composition including said glycerol derivatives |
| 04/11/2013 | WO2013050717A1 Method for preparing 1,2,3-trimethoxypropane, uses thereof, and compositions including said 1,2,3-trimethoxypropane |
| 04/11/2013 | WO2013050637A1 Oxoisoaporphine nanocapsules for treating depression |
| 04/11/2013 | WO2013050617A1 Structured polypeptides with sarcosine linkers |
| 04/11/2013 | WO2013050280A1 Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis |
| 04/11/2013 | WO2013020005A3 Oxazoline polymer compositions and use thereof |
| 04/11/2013 | WO2013019151A3 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
| 04/11/2013 | WO2013016697A3 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 04/11/2013 | WO2013012924A3 Engineered microbe-targeting molecules and uses thereof |
| 04/11/2013 | WO2013010840A3 Long acting luteinizing hormone (lh) compound |
| 04/11/2013 | WO2013009142A3 Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same |
| 04/11/2013 | WO2013006569A3 Herpes virus vaccine and methods of use |
| 04/11/2013 | WO2013004716A9 Peptide beads |
| 04/11/2013 | WO2013002580A3 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient |
| 04/11/2013 | WO2012172143A3 Alkyl gallate derivatives as antioxidants and surfactants |
| 04/11/2013 | WO2012153193A3 Protein-active agent conjugates and method for preparing the same |
| 04/11/2013 | WO2012072245A3 Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails |
| 04/11/2013 | WO2012068376A3 Keratin compositions for treatment of bone deficiency or injury |
| 04/11/2013 | WO2012006367A3 Compositions and methods for treating influenza |
| 04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
| 04/11/2013 | US20130090591 Localization of agents at a target site with a composition and an energy source |
| 04/11/2013 | US20130090458 Immunoconjugates with an Intracellularly-Cleavable Linkage |
| 04/11/2013 | US20130090391 Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
| 04/11/2013 | US20130090387 Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
| 04/11/2013 | US20130090384 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 04/11/2013 | US20130090365 Antimycotic pharmaceutical composition |
| 04/11/2013 | US20130090349 Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist |
| 04/11/2013 | US20130090343 Methods for administering aripiprazole |
| 04/11/2013 | US20130090313 pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
| 04/11/2013 | US20130090288 Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes |
| 04/11/2013 | US20130090287 Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents |
| 04/11/2013 | US20130090237 Pteredin pentanedioic derivative based nanoparticles |
| 04/11/2013 | US20130089671 Polymers formed from 2,3,3,3-tetrafluoropropene and articles and uses thereof |
| 04/11/2013 | US20130089604 Solid Oral Dosage Form Containing An Enhancer |
| 04/11/2013 | US20130089595 Controlled Release Formulations |
| 04/11/2013 | US20130089592 Method of producing a hydrogel |
| 04/11/2013 | US20130089585 Filler comprising beads |
| 04/11/2013 | US20130089577 Novel ester containing compositions and methods |
| 04/11/2013 | CA2851398A1 Compositions for the treatment of dry eye |
| 04/11/2013 | CA2851176A1 Stabilisation of polypeptides |
| 04/11/2013 | CA2850944A1 Human notch1 decoys |